StockData
Adagene Inc. logo

Adagene Inc. (ADAG) stock

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.48−0.12 (-7.50%)

Close on Nov 17, 2026Market cap $87.66MP/E –Yield –

Adagene operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$15.66M. The highest annual figure on record is -$14.26M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.66M–
FY2024Dec 31, 2024-$29.70M–
FY2023Dec 31, 2023-$28.45M–
FY2022Dec 31, 2022-$48.61M–
FY2021Dec 31, 2021-$43.41M–
FY2020Dec 31, 2020-$28.53M–
FY2019Dec 31, 2019-$18.15M–
FY2018Dec 31, 2018-$14.26M–

More Adagene figures

See a number that looks wrong?